Cargando…
Financial Toxicity and Societal Costs of Cancer Care: Distinct Problems Require Distinct Solutions
Control of societal costs can be addressed through clinician education, value‐based guidelines and pathways, formulary restrictions, payment reform, and government regulatory decisions but should not be imposed on patients at the point of decision‐making in the cancer clinic.
Autor principal: | Peppercorn, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330709/ https://www.ncbi.nlm.nih.gov/pubmed/28167570 http://dx.doi.org/10.1634/theoncologist.2016-0301 |
Ejemplares similares
-
End‐of‐Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs
por: Dalal, Shalini, et al.
Publicado: (2017) -
Getting Past No in Cancer Care
por: Kolodziej, Michael
Publicado: (2016) -
Value-Based Care in Lung Cancer
por: Eaton, Keith D., et al.
Publicado: (2016) -
Value: The Next Frontier in Cancer Care
por: Goulart, Bernardo H.L.
Publicado: (2016) -
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations
por: Schnipper, Lowell E., et al.
Publicado: (2016)